Growth hormone secretagogues like sermorelin, CJC-1295, and ipamorelin get pitched constantly to serious lifters and endurance athletes chasing faster recovery. Before you stack anything, you need to know what's actually legal for your sport, what requires lab-confirmed deficiency, and what a licensed clinician will and won't prescribe in 2026.
- Sermorelin injections are the steady baseline pick for adults with lab-confirmed GH deficiency — Buy if your IGF-1 is low and you're not competition-tested.
- CJC-1295 suits recovery-limited training schedules with twice-weekly dosing; growth hormone peptides for athletes under WADA testing should skip GH secretagogues entirely.
- BPC-157 targets tendon and ligament recovery, not the GH pathway, and pairs with a broader peptide therapy plan under monitoring.
- Hexarelin is the most potent GHRP available and the one most likely to desensitize receptors with overuse — Skip unless closely monitored.
Why this matters
Most "athlete stacks" sold online ignore one basic fact: growth hormone and GH-releasing peptides sit on the WADA Prohibited List under category S2, banned in and out of competition for tested athletes. That means this guide is written for adults training seriously but not subject to sport drug testing — masters lifters, recreational endurance athletes, and former competitors managing age-related decline in GH and IGF-1.
Rebody Health prescribes peptide therapy based on lab-confirmed need, reviewed by a licensed clinician, not to chase a competitive edge in a tested sport. If you compete under WADA, NCAA, or a similar body, growth hormone peptides for athletes disqualify you before you finish the vial.
Who this is for
This guide is for adults age 30 and up who train hard, aren't subject to competition drug testing, and want GH-pathway support for recovery, sleep, and lean muscle retention rather than a doping shortcut. If your IGF-1 comes back low on bloodwork and you're not stepping on a sanctioned platform in 2026, keep reading.
What to look for in growth hormone peptides for athletes
Lab-confirmed need, not guesswork
A clinician should order IGF-1 and GH-axis labs before prescribing anything. Peptide therapy started on symptoms alone — fatigue, slow recovery, poor sleep — without a baseline number is a guess, not a treatment plan.
Anti-doping and competition eligibility
Check your sport's testing status before anything else. GH secretagogues like sermorelin, CJC-1295, ipamorelin, and hexarelin fall under WADA's S2 category, and untested masters divisions treat this very differently than NCAA or Olympic-pathway competition.
Injection routine that fits training and travel
Sermorelin is typically dosed nightly, while CJC-1295 with a drug-affinity complex stretches to twice weekly. If you travel for meets or training camps, a twice-weekly protocol beats juggling a nightly cooler.
Recovery-first vs. sleep-first secretagogue selection
Some peptides push pulsatile GH release tied to deep sleep; others prioritize sustained IGF-1 elevation for tissue repair. Pick based on your actual limiter — if you're not sleeping, sleep-focused peptides matter more than a stronger GHRP.
Monitoring cadence and lab work
IGF-1 recheck at 8-12 weeks is standard for most GH secretagogue protocols, with a full metabolic panel every 3-6 months. Skipping follow-up labs is how receptor desensitization and blood sugar shifts go unnoticed.
Stack complexity vs. adherence
A three-peptide stack with different reconstitution schedules and injection windows fails when you're tired, traveling, or racing a deadline. Simpler protocols get used correctly; complicated ones get skipped.
Sermorelin injections remain the entry point most clinicians start with because the dosing is predictable and the safety data is the deepest of any GH secretagogue on this list.
Top picks
Sermorelin injections — the steady baseline pick. Nightly subcutaneous dosing mimics the body's natural GH pulse better than most alternatives, and it's the most-studied GH-releasing hormone analog in clinical use. Adults with confirmed GH deficiency and consistent nightly routines get the most out of it. Buy if your labs confirm low GH/IGF-1 and you're not competition-tested. See sermorelin injections for adult growth hormone deficiency.
CJC-1295 — the recovery specialist. Twice-weekly dosing with a drug-affinity complex extends its half-life well beyond sermorelin, which matters if your training schedule can't handle nightly injections. It's often paired with sleep-quality goals since GH release peaks during deep sleep cycles. Consider it if recovery between hard sessions is your main bottleneck. Read the CJC-1295 guide for deep sleep and recovery.
Ipamorelin plus CJC-1295 — the stack. Combining a selective GHRP with a longer-acting GHRH analog gives more consistent GH pulses than either peptide alone, without the appetite spike some older GHRPs cause. This combination shows up often in lean-muscle and anti-aging protocols for adults over 40. Consider it under active clinician monitoring, not as a self-directed add-on.
BPC-157 — the wildcard for nagging injuries. This isn't a GH-pathway peptide at all — it's used for tendon, ligament, and gut-lining recovery, which makes it a common companion to a GH secretagogue rather than a replacement for one. Athletes managing a stubborn Achilles or elbow issue reach for this specifically. Buy for injury-focused recovery, paired with rehab, not as a standalone fix. Check the BPC-157 injury recovery guide.
Hexarelin — the one to respect. It's the most potent GHRP available, but it desensitizes GH receptors faster than gentler options like ipamorelin, and cortisol/prolactin effects show up more often at higher doses. Skip it unless your clinician is running frequent labs and you have a specific reason to need that much GH signal.
Get labs before you pick a peptide
Talk to a licensed clinician about GH-axis testing and eligibility.
What to avoid
- GH secretagogues while under competition testing. WADA's S2 category catches sermorelin, CJC-1295, ipamorelin, and hexarelin regardless of dose or intent.
- Research-chemical sites with no clinician oversight. No baseline labs, no dosing guidance, no follow-up — that's not treatment, it's a guessing game with a needle.
- Stacking three or more secretagogues at once. More peptides doesn't mean more GH signal; it usually means faster receptor desensitization and a bigger blind spot in your monitoring.
Verdict comparison
| Peptide | Best for | Dosing frequency | Verdict |
|---|---|---|---|
| Sermorelin | Confirmed GH deficiency, predictable routine | Nightly | Buy |
| CJC-1295 | Recovery-limited schedules, sleep quality | Twice weekly | Consider |
| Ipamorelin + CJC-1295 | Lean muscle retention, combined GH pulse | Varies by protocol | Consider |
| BPC-157 | Tendon/ligament injury recovery | Per clinician protocol | Buy (injury-specific) |
| Hexarelin | Advanced cases under close monitoring | Multiple weekly doses | Skip for most |
FAQ
Are growth hormone peptides legal for competitive athletes?
Growth hormone secretagogues like sermorelin, CJC-1295, and ipamorelin are banned under WADA's S2 category for tested athletes in 2026. They remain legal by prescription for adults with diagnosed GH deficiency who aren't subject to competition drug testing.
What's the difference between sermorelin and CJC-1295?
Sermorelin is dosed nightly and mimics natural GH pulses closely, while CJC-1295 uses a drug-affinity complex to extend its effect to twice-weekly dosing. Clinicians pick based on routine fit and how consistently a patient can commit to injections.
Is ipamorelin banned by WADA?
Yes, ipamorelin falls under the same S2 growth hormone-releasing peptide category as sermorelin and CJC-1295. Any tested athlete using it risks disqualification regardless of the reason for use.
How long before growth hormone peptides show results?
Most protocols recheck IGF-1 labs at 8 to 12 weeks to confirm the dose is working. Subjective changes in sleep and recovery often show up sooner, but lab confirmation is what guides dose adjustments.
Can BPC-157 be combined with GH secretagogues?
Yes, BPC-157 targets tendon, ligament, and gut-lining repair rather than the GH pathway, so it's commonly paired with a secretagogue for athletes managing both recovery and a specific injury. A clinician should still review the combination.
How often do you need bloodwork on peptide therapy?
Standard GH secretagogue protocols recheck IGF-1 every 8 to 12 weeks and run a full metabolic panel every 3 to 6 months. Skipping labs is the most common reason people miss early signs of receptor desensitization.
Do growth hormone peptides help with weight loss?
GH secretagogues can support lean body composition indirectly by improving recovery and sleep, but they aren't weight-loss drugs the way semaglutide or tirzepatide are. Athletes looking for direct appetite or fat-loss effects need a different treatment category entirely.
What happens if you stop peptide therapy?
GH and IGF-1 levels typically return to baseline within weeks of stopping, since these peptides don't create the same lasting suppression seen with exogenous testosterone. Any recovery or sleep improvements gained during treatment fade back toward pre-treatment levels.
One last thing
Most people searching "growth hormone peptides for athletes" in 2026 aren't tested competitors at all — they're masters-division lifters and recreational endurance athletes managing GH decline that started well before they noticed it. The peptide that matters most isn't the strongest one on this list; it's the one your labs confirm you actually need, dosed on a schedule you'll follow past week three.